Jennifer Joy
Jennifer Joy Anderson Miller, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20140289873 | SYSTEM AND METHOD FOR AUTOMATED LICENSING IDENTIFICATION AND VERIFICATION - A system for license identification and verification uses watermarking technology to embed license information in the medium itself. Various techniques for the creation of the license are described. The Platform on which the media will be used can extract the watermark data and thereby identify and verify the license. The watermark data includes a certain minimal amount of license data. If further information is required, the Platform can use the watermark data to request additional license details from a Licensor or from a license server. Using this approach, the Platform can readily identify and verify that the media in its possession is properly licensed. | 09-25-2014 |
Jennifer Joy Kordich, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20120070432 | TREATMENT OF PANCREATIC CANCER USING A DR5 AGONIST IN COMBINATION WITH GEMCITABINE - Methods and compositions for treatment of exocrine pancreatic cancer in a human patient comprising administering a therapeutically effective amount of a DR5 agonist and gemcitabine. Methods and compositions for treating a patient by identifying the alleleic variant of FcγRIIIA. | 03-22-2012 |
Jennifer Joy Kordich, Sammamish, WA US
Patent application number | Description | Published |
---|---|---|
20130064838 | ENHANCED DEATH RECEPTOR AGONISTS - Methods and compositions for treatment of cancer in a human patient comprising administering a therapeutically effective amount of an Fc-polypeptide agonist of DR5 having high-affinity to FCGR3A. Methods of making the Fc-polypeptides are provided. | 03-14-2013 |
20130095111 | FUSION PROTEINS IN CANCER - The present invention provides fusion proteins expressed by cancer cells, antibodies and other antigen-binding agents that specifically bind to the fusion proteins, and compositions and methods for using the antibodies and other antigen-binding agents to detect, characterize, and treat cancer. | 04-18-2013 |
Jennifer Joy Kordich, Ada, MI US
Patent application number | Description | Published |
---|---|---|
20150056204 | DR5 RECEPTOR AGONIST COMBINATIONS - The present invention includes apoptotic compositions and methods for inducing apoptosis of cancer cells independent of NK cells. An apoptotic composition comprises a cooperative combination of antibodies that specifically bind to human DR5, or a cooperative combination of an anti-DR5 antibody and TRAIL. Administration of therapeutically effective amounts of an apoptotic composition induces apoptosis of apoptosis sensitive cancer cells. | 02-26-2015 |